litlas
ログインアカウント作成

Milind Javle

1997–2025 年に発表

145
論文数
18,145
被引用数
75
h 指数
134
i10 指数

被引用数

Milind Javle の年別被引用数1939 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 1 件2004 年: 被引用 5 件2005 年: 被引用 5 件2006 年: 被引用 8 件2007 年: 被引用 13 件2008 年: 被引用 9 件2009 年: 被引用 16 件2010 年: 被引用 17 件2011 年: 被引用 23 件2012 年: 被引用 72 件2013 年: 被引用 61 件2014 年: 被引用 54 件2015 年: 被引用 74 件2016 年: 被引用 84 件2017 年: 被引用 102 件2018 年: 被引用 101 件2019 年: 被引用 542 件2020 年: 被引用 903 件2021 年: 被引用 933 件2022 年: 被引用 942 件2023 年: 被引用 718 件2024 年: 被引用 1,253 件2025 年: 被引用 586 件2026 年: 被引用 14 件1940〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,851 件、この内訳の 25.5%中国: 引用元論文 1,004 件、この内訳の 13.9%イタリア: 引用元論文 448 件、この内訳の 6.2%ドイツ: 引用元論文 372 件、この内訳の 5.1%イギリス: 引用元論文 343 件、この内訳の 4.7%日本: 引用元論文 304 件、この内訳の 4.2%フランス: 引用元論文 277 件、この内訳の 3.8%韓国: 引用元論文 232 件、この内訳の 3.2%スペイン: 引用元論文 230 件、この内訳の 3.2%カナダ: 引用元論文 198 件、この内訳の 2.7%オランダ: 引用元論文 176 件、この内訳の 2.4%インド: 引用元論文 146 件、この内訳の 2%
0%25.5%その他 23.1%

機関

分野

  • Medicine66.2%
  • Biochemistry, Genetics and Molecular Biology28.9%
  • Immunology and Microbiology1.9%
  • Physics and Astronomy0.8%
  • Engineering0.4%
  • Materials Science0.4%
  • その他1.4%

トピック

  • Cholangiocarcinoma and Gallbladder Cancer Studies10.4%
  • Pancreatic and Hepatic Oncology Research9.1%
  • Gallbladder and Bile Duct Disorders4.7%
  • Cancer Genomics and Diagnostics3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis3.1%
  • Cancer Immunotherapy and Biomarkers2%
  • その他66.8%

共著者

全論文

検索で開く
  1. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

    著者: Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Bridgewater, William Proctor Harris, Adrian Murphy, Do‐Youn Oh, Jonathan Whisenant, Maeve A. Lowery, Lipika Goyal, Rachna T. Shroff, Anthony B. El-Khoueiry, Bin Fan, Bin Wu, Christina X. Chamberlain, Liewen Jiang, Camelia Gliser, Shuchi S. Pandya, Juan W. Valle, Andrew X. Zhu - The Lancet Oncology 2020 被引用: 1,075

  2. Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation

    著者: Andrew X. Zhu, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Bridgewater, William Proctor Harris, Adrian Murphy, Do‐Youn Oh, Jonathan Whisenant, Maeve A. Lowery, Lipika Goyal, Rachna T. Shroff, Anthony B. El-Khoueiry, Christina X. Chamberlain, Elia Aguado-Fraile, Sung Choe, Bin Wu, Hua Liu, Camelia Gliser, Shuchi S. Pandya, Juan W. Valle, Ghassan K. Abou‐Alfa - JAMA Oncology 2021 被引用: 473

  3. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

    著者: Milind Javle, Sameek Roychowdhury, Robin Kate Kelley, Saeed Sadeghi, Teresa Macarulla, Karl Heinz Weiss, Dirk‐Thomas Waldschmidt, Lipika Goyal, Ivan Borbath, Anthony B. El-Khoueiry, Mitesh J. Borad, Wei Peng Yong, Philip A. Philip, Michael Bitzer, S. Tanasanvimon, Li Ai, Amit Pande, Harris S. Soifer, Stacie Peacock Shepherd, Susan Moran, Andrew X. Zhu, Tanios Bekaii‐Saab, Ghassan K. Abou‐Alfa - ˜The œLancet. Gastroenterology & hepatology 2021 被引用: 425

  4. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

    著者: James J. Harding, Jia Fan, Do‐Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui‐Chuan Sun, Teresa Macarulla, Feng Xie, Jean‐Philippe Metges, Jieer Ying, John Bridgewater, Myung Ah Lee, Mohamedtaki Abdulaziz Tejani, Emerson Y. Chen, Dong Uk Kim, Harpreet Wasan, Michel Ducreux, Yuanyuan Bao, Lisa Boyken, Jiafang Ma, Phillip M. Garfin, Shubham Pant, Ghassan K. Abou‐Alfa, J. Adeva Alfonso, Massimo Aglietta, Ari David Baron, Muhammad Shaalan Beg, Paula Carrasco Aguirre, Eric X. Chen, Ying Cheng, Antonio Cubillo Gracián, Laëtitia Dahan, Filippo de Braud, Elisabetta Fenocchio, Olumide Gbolohon, Roopinder Gillmore, Marine Jary, Milind Javle, Yixing Jiang, Jung Hun Kang, Gentry George King, Madappa N. Kundranda, Laura Layos, Daneng Li, Tingbo Liang, Sara Lonardi, Omkar Marathe, Sebastián Mondaca, Andrés J. Muñoz Martín, Joon Oh Park, Roberto Pazo-Cid, Paula Ribera Fernandez, Lorenza Rimassa, Rosa Alonso, Saeed Sadeghi, Aaron J. Scott, Benjamin Tan, David Tougeron, Qiang Yan, Xiaoyu Yin, Haitao Zhao - The Lancet Oncology 2023 被引用: 247

  5. Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study

    著者: Milind Javle, Mitesh J. Borad, Nilofer S. Azad, Razelle Kurzrock, Ghassan K. Abou‐Alfa, Ben George, John D. Hainsworth, Funda Meric‐Bernstam, Charles Swanton, Christopher J. Sweeney, Claire F. Friedman, Ron Bose, David R. Spigel, Yong Wang, Jonathan Levy, Katja Schulze, Vaikunth Cuchelkar, Arisha Patel, Howard A. Burris - The Lancet Oncology 2021 被引用: 406

  6. Gallbladder cancer

    著者: Juan Carlos Roa, Patricia García, Vinay K. Kapoor, Shishir K. Maithel, Milind Javle, Jill Koshiol - Nature Reviews Disease Primers 2022 被引用: 403

  7. Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

    著者: Vivek Subbiah, Ulrik Lassen, Élena Elez, Antoîne Italiano, Giuseppe Curigliano, Milind Javle, Filippo de Braud, Gerald W. Prager, Richard Greil, Alexander Stein, Angelica Fasolo, Jan H.M. Schellens, Patrick Y. Wen, Kert Viele, Aislyn Boran, Eduard Gasal, Paul Burgess, Palanichamy Ilankumaran, Zev A. Wainberg - The Lancet Oncology 2020 被引用: 518

  8. Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

    著者: Milind Javle, Maeve A. Lowery, Rachna T. Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J. Borad, Ramesh K. Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla, Anthony B. El-Khoueiry, Robin Kate Kelley, Ivan Borbath, Su Pin Choo, Do‐Youn Oh, Philip A. Philip, Li‐Tzong Chen, Thanyanan Reungwetwattana, Eric Van Cutsem, Kun‐Huei Yeh, Kristen K. Ciombor, Richard S. Finn, Anuradha Patel, Suman Sen, Dale Porter, Randi Isaacs, Andrew X. Zhu, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab - Journal of Clinical Oncology 2017 被引用: 715

  9. Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study

    著者: Funda Meric‐Bernstam, Rastislav Bahleda, Cinta Hierro, Marc Sanson, John Bridgewater, Hendrik‐Tobias Arkenau, Ben Tran, Robin Kate Kelley, Joon Oh Park, Milind Javle, Yaohua He, Karim A. Benhadji, Lipika Goyal - Cancer Discovery 2021 被引用: 248

  10. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

    著者: Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed O. Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios Bekaii‐Saab, Mitesh J. Borad - JAMA Oncology 2019 被引用: 473

  11. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients

    著者: J. Castillo, Vincent Bernard, F. Anthony San Lucas, Kelvin Allenson, Michela Capello, D.U. Kim, Peter R. C. Gascoyne, Feven C. Mulu, Bret M. Stephens, Jonathan Huang, H. Wang, Amin A. Momin, Rodrigo Jácamo, Matthew H. G. Katz, Robert A. Wolff, Milind Javle, Gauri R. Varadhachary, Ignacio I. Wistuba, Samir Hanash, Anirban Maitra, Héctor M. Álvarez - Annals of Oncology 2017 被引用: 271

  12. Biliary cancer: Utility of next‐generation sequencing for clinical management

    著者: Milind Javle, Tanios Bekaii‐Saab, Apurva Jain, Ying Wang, Robin Katie Kelley, Kai Wang, Hyunseon C. Kang, Daniel V.T. Catenacci, Siraj M. Ali, Sunil Krishnan, Daniel H. Ahn, Andrea Grace Bocobo, Mingxin Zuo, Ahmed O. Kaseb, Vincent A. Miller, Philip J. Stephens, Funda Meric‐Bernstam, Rachna T. Shroff, Jeffrey S. Ross - Cancer 2016 被引用: 405

  13. FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

    著者: Anuhya Kommalapati, Sri Harsha Tella, Mitesh J. Borad, Milind Javle, Amit Mahipal - Cancers 2021 被引用: 152

  14. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

    著者: Vincent Bernard, Dong U. Kim, F. Anthony San Lucas, Jonathan Castillo, Kelvin Allenson, Feven C. Mulu, Bret M. Stephens, Jonathan Huang, Alexander Semaan, Paola A. Guerrero, Nabiollah Kamyabi, Jun Zhao, Mark W. Hurd, Eugene J. Koay, Cullen M. Taniguchi, Joseph M. Herman, Milind Javle, Robert A. Wolff, Matthew H. G. Katz, Gauri R. Varadhachary, Anirban Maitra, Hector A. Alvarez - Gastroenterology 2018 被引用: 371

  15. Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

    著者: Aislyn Schalck, Donastas Sakellariou-Thompson, Marie‐Andrée Forget, Emi Sei, Tara G. Hughes, Alexandre Reuben, Shanshan Bai, Min Hu, Tapsi Kumar, Mark W. Hurd, Matthew H. G. Katz, Ching‐Wei D. Tzeng, Shubham Pant, Milind Javle, David R. Fogelman, Anirban Maitra, Cara Haymaker, Michael P. Kim, Nicholas E. Navin, Chantale Bernatchez - Cancer Discovery 2022 被引用: 79

  16. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series

    著者: Keri E. Lunsford, Milind Javle, Kirk Heyne, Rachna T. Shroff, Reham Abdel‐Wahab, Nakul Gupta, Constance M. Mobley, Ashish Saharia, David W. Victor, Duc T. Nguyen, Edward A. Graviss, Ahmed O. Kaseb, Robert McFadden, Thomas A. Aloia, Claudius Conrad, Li X, Howard Monsour, A. Osama Gaber, Jean‐Nicolas Vauthey, R. Mark Ghobrial - ˜The œLancet. Gastroenterology & hepatology 2018 被引用: 292

  17. SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

    著者: Rachna T. Shroff, Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind Javle, Carol Aghajanian, Benjamin Tan, P. Cheema, Anuj Patel, Renuka Iyer, Robin Kate Kelley, Jaykumar Thumar, Anthony B. El-Khoueiry, E. Gabriela Chiorean, Howard S. Höchster, Philip Agop Philip - Journal of Clinical Oncology 2023 被引用: 99

  18. Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

    著者: Chaitanya Churi, Rachna T. Shroff, Ying Wang, Asif Rashid, Hyunseon C. Kang, J. Weatherly, Mingxin Zuo, Ralph Zinner, David S. Hong, Funda Meric‐Bernstam, Filip Jankú, Christopher H. Crane, Lopa Mishra, J.N. Vauthey, Robert A. Wolff, Gordon B. Mills, Milind Javle - PLoS ONE 2014 被引用: 454

  19. Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma

    著者: Robert McMillan, Milind Javle, Sudha Kodali, Ashish Saharia, Constance M. Mobley, Kirk Heyne, Mark J. Hobeika, Keri E. Lunsford, David W. Victor, Akshay Shetty, Robert McFadden, Maen Abdelrahim, Ahmed S. Kaseb, Mukul Divatia, Nam Chol Yu, Joy Nolte Fong, Linda W. Moore, Duc T. Nguyen, Edward A. Graviss, A. Osama Gaber, Jean‐Nicolas Vauthey, R. Mark Ghobrial - American Journal of Transplantation 2021 被引用: 124

  20. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

    著者: Milind Javle, Sunyoung Lee, Nilofer S. Azad, Mitesh J. Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora A. Janjan, Shreekant Parasuraman, Tanios Bekaii‐Saab - The Oncologist 2022 被引用: 84

  21. Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

    著者: Changhoon Yoo, Milind Javle, Helena Verdaguer Mata, Filippo de Braud, Jörg Trojan, Jean‐Luc Raoul, Jin Won Kim, Makoto Ueno, Choong‐kun Lee, Susumu Hijioka, Antonio Cubillo, Junji Furuse, Nilofer S. Azad, Masashi Sato, Yulia Vugmeyster, Andreas Machl, Marcis Bajars, John Bridgewater, Do‐Youn Oh, Mitesh J. Borad - Hepatology 2023 被引用: 49

  22. Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

    著者: Giampaolo Perri, Laura Prakash, Wei Qiao, Gauri R. Varadhachary, Robert A. Wolff, David R. Fogelman, Michael J. Overman, Shubham Pant, Milind Javle, Eugene J. Koay, Joseph M. Herman, Michael P. Kim, Naruhiko Ikoma, Ching‐Wei D. Tzeng, Jeffrey E. Lee, Matthew H. G. Katz - JAMA Surgery 2020 被引用: 179

  23. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

    著者: Rodabe N. Amaria, Anne Knisely, David Vining, Scott Kopetz, Michael J. Overman, Milind Javle, Mara B. Antonoff, Ching‐Wei D. Tzeng, Robert A. Wolff, Shubham Pant, Kathryn Lito, Kelly Rangel, Bryan Fellman, Ying Yuan, Karen H. Lu, Donastas Sakellariou-Thompson, Cara Haymaker, Marie‐Andrée Forget, Patrick Hwu, Chantale Bernatchez, Amir A. Jazaeri - Journal for ImmunoTherapy of Cancer 2024 被引用: 52

  24. The role of PARP in DNA repair and its therapeutic exploitation

    著者: Milind Javle, Nicola J. Curtin - British Journal of Cancer 2011 被引用: 326